13668-0735 Pazopanib - CanMED: NDC

Product NDC:

13668-0735

Brand Name:

Pazopanib

Generic Name:

Pazopanib hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: PAZOPANIB HYDROCHLORIDE

Strength: 400.0

Unit: mg/1

Packages:

Code: 13668-0735-30

Description: 30 TABLET, FILM COATED in 1 BOTTLE (13668-735-30)

Effective Date: Sept. 4, 2025

Discontinued:

Code: 13668-0735-60

Description: 60 TABLET, FILM COATED in 1 BOTTLE (13668-735-60)

Effective Date: Sept. 4, 2025

Discontinued:

Code: 13668-0735-90

Description: 90 TABLET, FILM COATED in 1 BOTTLE (13668-735-90)

Effective Date: Sept. 4, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

VEGFR, PDGFR, FGFR, Kit, Itk, Lck, c-Fms

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox